Coral Laboratories Ltd. (CORALAB) 52 Week High Streak: Consecutive High Analysis
- November 20, 2026
- Posted by: Chaitanya Auti
- Category: News
Coral Laboratories Ltd. has now traded within 2% of its 52-week high for a second consecutive session, and the move across that streak stands at 8.69%. As of 20 November 2026 at 9:52 AM IST, the stock was trading at Rs 675.05 after touching a high of Rs 690. The latest Univest data confirms the pattern, but it does not establish a company-specific catalyst for the continued move.
The stock had earlier opened at Rs 674.90 and touched a low of Rs 671.20, while the previous close was Rs 663.75. Coral Laboratories Ltd. now carries a market capitalisation of Rs 237.13 crore. For readers, the repeated proximity to the one-year high is more informative than a single-day move because it shows the stock has stayed near the upper end of its recent range across back-to-back sessions.
Coral Laboratories Ltd. 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 675.05 |
| Previous Close | Rs 663.75 |
| Today's Move | +Rs 11.3 (+1.7%) |
| Open | Rs 674.9 |
| High | Rs 690 |
| Low | Rs 671.2 |
| Market Capitalisation | Rs 237.13 crore |
Coral Laboratories Ltd. (CORALAB) traded at Rs 675.05 versus the previous close of Rs 663.75, a rise of 1.7%. The stock opened at Rs 674.9, reached a high of Rs 690 and touched a low of Rs 671.2.
Coral Laboratories Ltd. is trading at Rs 675.05, which is Rs 11.30 above the previous close of Rs 663.75, or 1.7% higher. The share opened at Rs 674.90, moved to a high of Rs 690 and a low of Rs 671.20, and was positioned in the upper half of that range at the time of the update. The market capitalisation stands at Rs 237.13 crore.
That intraday pattern matters because it places Coral Laboratories Ltd. close to its upper range while remaining within the broader near-52-week-high zone that has persisted for two sessions. The stock’s current trade level is above the previous close, but the more important story for this article is that the higher-price zone has been repeated across sessions rather than appearing only once. For investors scanning Coral Laboratories Ltd. Share Price updates, the combination of a firm day move and a multi-session near-high pattern is the key context. Coral Laboratories Ltd. Stock News searches often focus on single-session spikes, but this case is about continued trade near the yearly high.
What the Repeated 52-Week Highs Show
The repeated near-high pattern suggests that Coral Laboratories Ltd. has stayed close to its 52-week peak for multiple sessions, with the streak move reaching 8.69% across the period. This is the main differentiator from a one-day breakout story. The latest Univest figures confirm the persistence of the price band, but they do not identify a company-specific reason behind the move.
For market readers, the relevance lies in continuity. A stock that keeps trading near its yearly high for a second session is being observed differently from one that briefly spikes and then fades. Still, this article does not convert that pattern into a directional call. Coral Laboratories Ltd. 52 Week High Streak coverage is best read as a factual note that the stock has remained near its 52-week high while continuing to trade in active discovery around that zone. Searches such as Coral Laboratories Ltd. Stock Performance, Coral Laboratories Ltd. Share Price Update and 52 Week High Stocks are often driven by this exact type of repetition.
Coral Laboratories Ltd. (CORALAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 237.13 crore |
| P/E Ratio | 10.84x |
| P/B Ratio | 1.05x |
| ROE | 7.98% |
| ROCE | 11.14% |
| EPS | Rs 61.23 |
| Book Value Per Share | Rs 633.28 |
| Dividend Yield | 0.3% |
Coral Laboratories Ltd. (CORALAB) fundamental metrics show P/E 10.84x, P/B 1.05x, ROE 7.98%, ROCE 11.14%. These figures provide context only and are not a buy or sell signal.
Coral Laboratories Ltd. has a market capitalisation of Rs 237.13 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 10.84x, P/B at 1.05x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.98% and ROCE of 11.14%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 61.23, book value per share of Rs 633.28, dividend yield of 0.3%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.6x, median ROE of 11.22%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 10.84x |
| Benchmark Median P/E | 26.6x |
| Benchmark Average P/E | 51.26x |
| Benchmark P/E Range | 0x to 1,399.41x |
| Company P/B Ratio | 1.05x |
| Benchmark Median P/B | 2.84x |
| Company ROE | 7.98% |
| Benchmark Median ROE | 11.22% |
| Company ROCE | 11.14% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 237.13 crore |
| Benchmark Median Market Cap | Rs 790.89 crore |
Coral Laboratories Ltd. (CORALAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Coral Laboratories Ltd. (CORALAB) has a P/E ratio of 10.84x, which is below the benchmark median of 26.6x, a difference of -59.25%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Coral Laboratories Ltd. (CORALAB) has a ROE of 7.98%, which is below the benchmark median of 11.22%, a difference of -28.88%. Coral Laboratories Ltd. (CORALAB) has a ROCE of 11.14%, which is below the benchmark median of 13.1%, a difference of -14.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Zenotech Laboratories Ltd. | ZENOTECH | 239.85 | 0 | 2.56 | -1.12 | 4.38 |
| Accretion Nutraveda Ltd. | ANL | 243.99 | 48.14 | 7.73 | 27.68 | 30.19 |
| BDH Industries Ltd. | BDH | 229.08 | 20.14 | 2.94 | 15.11 | 20.88 |
| Accretion Pharmaceuticals Ltd. | ACCPL | 226.77 | 23.46 | 4.35 | 28.72 | 29.77 |
| iStreet Network Ltd. | ISTRNETWK | 248.65 | 45.94 | 4.72 | 32.44 | 23.73 |
Coral Laboratories Ltd. (CORALAB) has a P/E ratio of 10.84x compared with the displayed peer median of 23.46x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.98% compares with a peer median of 27.68% across the companies shown in the table. ROCE stood at 11.14% versus the displayed peer median of 23.73%, providing a capital-efficiency comparison. Coral Laboratories Ltd. (CORALAB) has a market capitalisation of Rs 237.13 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Coral Laboratories Ltd.
- The stock has traded within 2% of its 52-week high for a second consecutive session.
- The streak move across the period stands at 8.69%.
- The share is trading at Rs 675.05 versus the previous close of Rs 663.75.
- The company is valued at Rs 237.13 crore in market capitalisation.
- Its P/E of 10.84 and P/B of 1.05 are below the industry medians in the latest Univest comparison.
About Coral Laboratories Ltd.
Coral Laboratories Ltd. is part of the Pharmaceuticals & Drugs industry in the Healthcare sector. The company is tracked on NSE and BSE under the symbol CORALAB. In the latest market snapshot, the business is shown with a market capitalisation of Rs 237.13 crore, alongside valuation and return ratios that place it in a lower-than-median valuation band versus the industry comparison set.
For readers following Coral Laboratories Ltd. Stock News, the relevant context is not only the price proximity to the one-year high but also the broader company profile that sits behind that move. The combination of a modest P/E, a near-par book value multiple and sub-median return ratios makes the stock worth watching for how it behaves after repeated high-zone trading.
What does Coral Laboratories Ltd. 52 Week High Streak mean?
It means Coral Laboratories Ltd. has traded within 2% of its 52-week high for consecutive sessions. In this case, the streak has lasted for a second consecutive session, which places the stock in a repeated near-high pattern rather than a one-day move.
How much has Coral Laboratories Ltd. moved across the streak?
According to latest Univest data, the cumulative move across the streak is 8.69%. That is the key figure for this article because it captures the full repeated-high pattern rather than only the latest intraday change.
What is Coral Laboratories Ltd. trading at now?
As of 20 November 2026 at 9:52 AM IST, Coral Laboratories Ltd. was trading at Rs 675.05. The stock was above its previous close of Rs 663.75 and had touched a high of Rs 690 during the update.
Did Coral Laboratories Ltd. set a new 52-week high today?
No. The data shows that the stock traded near its 52-week high, but it does not state that a new annual peak was set. The focus here is the repeated proximity to that level across two sessions.
Is there a company-specific catalyst confirmed for the move?
No company-specific catalyst is confirmed by the latest Univest data. The numbers confirm the repeated near-high price pattern, but they do not identify a fundamental, corporate or sector-specific trigger for the continued trade.
How does Coral Laboratories Ltd. look on valuation?
The stock has a P/E of 10.84 and a P/B of 1.05. Those levels are below the industry medians in the latest Healthcare comparison set, which makes the valuation look modest versus the broader Pharmaceuticals & Drugs universe.
How does Coral Laboratories Ltd. compare with peers?
Compared with selected peers, Coral Laboratories Ltd. trades at a lower P/E than several names such as Accretion Nutraveda Ltd., Accretion Pharmaceuticals Ltd. and iStreet Network Ltd. Its P/B also sits below most of the peer set shown.
What should investors monitor next?
Investors can watch whether Coral Laboratories Ltd. continues to trade near its yearly high, how the price behaves relative to the current range, and whether subsequent sessions extend the repeated-high pattern. The valuation profile and sector comparison remain relevant to that read.
Track Coral Laboratories Ltd. (CORALAB) Share Price on Univest
Use Coral Laboratories Ltd. (CORALAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.